Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter to the Editor
  • Published:

Long-term complete clinical and hematological responses of the TEMPI syndrome after autologous stem cell transplantation

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1

References

  1. Sykes DB, Schroyens W, O'Connell C . The TEMPI syndrome—a novel multisystem disease. N Engl J Med 2011; 365: 475–477.

    Article  CAS  Google Scholar 

  2. Jasim S, Mahmud G, Bastani B, Fesler M . Subcutaneous bortezomib for treatment of TEMPI syndrome. Clin Lymphoma Myeloma Leuk 2014; 14: e221–e223.

    Article  Google Scholar 

  3. Kwok M, Korde N, Landgren O . Bortezomib to treat the TEMPI syndrome. N Engl J Med 2012; 366: 1843–1845.

    Article  CAS  Google Scholar 

  4. Rosado FG, Oliveira JL, Sohani AR, Schroyens W, Sykes DB, Kenderian SS et al. Bone marrow findings of the newly described TEMPI syndrome: when erythrocytosis and plasma cell dyscrasia coexist. Mod Pathol 2015; 28: 367–372.

    Article  Google Scholar 

  5. Schroyens W, O'Connell C, Sykes DB . Complete and partial responses of the TEMPI syndrome to bortezomib. N Engl J Med 2012; 367: 778–780.

    Article  CAS  Google Scholar 

  6. Viglietti D, Sverzut JM, Peraldi MN . Perirenal fluid collections and monoclonal gammopathy. Nephrol Dial Transplant 2012; 27: 448–449.

    Article  Google Scholar 

  7. Dispenzieri A . POEMS syndrome: 2011 update on diagnosis, risk-stratification, and management. Am J Hematol 2011; 86: 591–601.

    Article  Google Scholar 

  8. Jain T, Offord CP, Kyle RA, Dingli D . Schnitzler syndrome: an under-diagnosed clinical entity. Haematologica 2013; 98: 1581–1585.

    Article  Google Scholar 

  9. Lacy MQ, Hogan WJ, Gertz MA, Dispenzieri A, Rajkumar SV, Hayman S et al. Successful treatment of scleromyxedema with autologous peripheral blood stem cell transplantation. Arch Dermatol 2005; 141: 1277–1282.

    Article  Google Scholar 

  10. Dispenzieri A, Seenithamby K, Lacy MQ, Kumar SK, Buadi FK, Hayman SR et al. Patients with immunoglobulin light chain amyloidosis undergoing autologous stem cell transplantation have superior outcomes compared with patients with multiple myeloma: a retrospective review from a tertiary referral center. Bone Marrow Transplant 2013; 48: 1302–1307.

    Article  CAS  Google Scholar 

  11. D'Souza A, Lacy M, Gertz M, Kumar S, Buadi F, Hayman S et al. Long-term outcomes after autologous stem cell transplantation for patients with POEMS syndrome (osteosclerotic myeloma): a single-center experience. Blood 2012; 120: 56–62.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M Q Lacy.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kenderian, S., Rosado, F., Sykes, D. et al. Long-term complete clinical and hematological responses of the TEMPI syndrome after autologous stem cell transplantation. Leukemia 29, 2414–2416 (2015). https://doi.org/10.1038/leu.2015.298

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/leu.2015.298

This article is cited by

Search

Quick links